Clinical Trials Browser

Phase 2 × INDUSTRY × Muscle Invasive Bladder Carcinoma × Clear all

NCT05297552 2024-02-20

A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Phase 2 Unknown

Muscle Invasive Bladder Carcinoma